Concepedia

K. Dawn Bryant

KD

3

Publications

192

Citations

3

H-Index

2010

Active since

Affiliations

Senex Biotechnology (United States)(Current)

K. Dawn Bryant is an author at Senex Biotechnology (United States) specializing in drug discovery, natural sciences, and medicinal chemistry.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryChemical BiologyNatural SciencesMedicinal ChemistryBioorganic ChemistryMolecular Pharmacology

Publications per year

2010–2011

3

Publications

3

INX-08189, a Phosphoramidate Prodrug of 6-<i>O</i>-Methyl-2′-<i>C</i>-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties

John Vernachio, Blair Bleiman, K. Dawn Bryant et al. · Antimicrobial Agents and Chemotherapy · 2011 · 84 citations · Full text

Phosphoramidate ProTides of 2′-<i>C</i>-Methylguanosine as Highly Potent Inhibitors of Hepatitis C Virus. Study of Their in Vitro and in Vivo Properties

Christopher McGuigan, Arnaud Gilles, Karolina Madela et al. · Journal of Medicinal Chemistry · 2010 · 56 citations

Phosphorodiamidates as a Promising New Phosphate Prodrug Motif for Antiviral Drug Discovery: Application to Anti-HCV Agents

Christopher McGuigan, Karolina Madela, Mohamed Aljarah et al. · Journal of Medicinal Chemistry · 2011 · 52 citations

Bioorganic Chemistry, Amino Acids, Phosphorodiamidate Prodrug Method +16

Rows per page

1–3 of 3